| dc.contributor.author | Ethiopian Food and Drug Authority | |
| dc.date.accessioned | 2026-02-24T08:21:02Z | |
| dc.date.available | 2026-02-24T08:21:02Z | |
| dc.date.issued | Dec 2025 | |
| dc.identifier.uri | http://repository.iphce.org/xmlui/handle/123456789/5338 | |
| dc.description.abstract | Reliable, timely, and evidence-based drug information (DI) is vital to patient safety, rational medicine use, and regulatory decision-making. In Ethiopia, gaps in access to high-quality DI Services (DIS) contribute to avoidable adverse drug events, and inefficient use of limited health resources. Strengthening DIS is therefore a national priority. | en_US |
| dc.language.iso | en_US | en_US |
| dc.subject | Medical supplies | en_US |
| dc.title | Guideline for drug information services | en_US |
| dc.type | Guideline | en_US |